부산대학교 도서관

El Hajj Chehade, Razane; Nawfal, Rashad; Semaan, Karl; Eid, Marc; Saad, Eddy; Machaalani, Marc; Yekeduz, Emre; Steiner, Clara; Daoud Khatoun, Wassim; Maj, David; Zarba, Martin; Wells, Connor; Pal, Sumanta Kumar; Suárez, Cristina; Takemura, Kosuke; Li, Haoran; Baca, Sylvan C; Xie, Wanling; Heng, Daniel Yick Chin; Choueiri, Toni K.

Journal of Clinical Oncology. 2025 Supllement 16, Vol. 43, p4556-4556. 132p.

El Hajj Chehade, Razane; Semaan, Karl; Zhang, Ze; Phillips, Noa; Canniff, John; Savignano, Hunter; Nawfal, Rashad; Eid, Marc; Grisham, Lexi; Prather, Rebecca; Beckermann, Katy; Vaishampayan, Ulka; Haas, Naomi; Hammers, Hans; McDermott, David; Wood, Lauren; Solley, Travis; Rini, Brian; Jonasch, Eric; Choueiri, Toni K; Freedman, Matthew L; Haake, Scott M; Baca, Sylvan C; Berchuck, Jacob E

Oncologist

El Zarif, Talal; Semaan, Karl; Xie, Wanling; Eid, Marc; Zarba, Martin; Issa, Wadih; Zhang, Tian; Nguyen, Charles B; Alva, Ajjai; Fahey, Catherine C; Beckermann, Kathryn E; Karam, Jose A; Campbell, Matthew T; Procopio, Giuseppe; Stellato, Marco; Buti, Sebastiano; Zemankova, Anezka; Melichar, Bohuslav; Massari, Francesco; Mollica, Veronica; Venugopal, Balaji; Ebrahimi, Hedyeh; de Velasco, Guillermo; Gurney, Howard Paul; De Giorgi, Ugo; Parikh, Omi; Winquist, Eric; Master, Viraj; Garcia, Abraham Ruiz; Cutuli, Hernan Javier; Ferguson, Thomas Robert; Gross-Goupil, Marine; Baca, Sylvan C; Pal, Sumanta K; Braun, David A; McKay, Rana R; Heng, Daniel Y C; Choueiri, Toni K

European Urology. 86:503-512

Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Siegmund SE; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Wu SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; El Hajj Chehade R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Gulati GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Phillips N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; French CA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Jacene HA; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA, USA.; Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. sylvan_baca@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. sylvan_baca@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. sylvan_baca@dfci.harvard.edu.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jberchuck@emory.edu.; Winship Cancer Institute of Emory University, Atlanta, GA, USA. jberchuck@emory.edu.; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA. jberchuck@emory.edu.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Machaalani, Marc; Eid, Marc; Semaan, Karl; Chehade, Razane El Hajj; Nawfal, Rashad; Baca, Sylvan C; Choueiri, Toni K

Oncologist; Oct2024, Vol. 29 Issue 10, p821-823, 3p

Adib E; Brigham and Women's Hospital Boston United States.; Nassar AH; Yale Cancer Center New Haven, CT United States.; Alaiwi SA; Yale New Haven Hospital United States.; Baca SC; Hungarian Academy of Sciences Boston United States.; Hanlon T; Dana-Farber/Harvard Cancer Center Boston United States.; Bou Farhat E; Brigham and Women's Hospital and Harvard Medical School Boston, MA United States.; Tang Y; Brigham and Women's Hospital Boston, MA United States.; Corona RI; UCLA Medical Center United States.; Seo JH; Dana-Farber Cancer Institute BOSTON, Massachusetts United States.; Fonseca MAS; Stanford Medicine Stanford, CA United States.; Acosta AM; Indiana University - Purdue University Indianapolis Indianapolis, MA United States.; Losko M; Brigham and Women's Hospital United States.; Zhang Z; Dana-Farber Cancer Institute United States.; Hirsch MS; Brigham and Women's Hospital Boston, MA United States.; Gusev A; Dana-Farber Cancer Institute Boston United States.; Lawrenson K; The University of Texas Health Science Center at San Antonio San Antonio, TX United States.; Mouw KW; Dana-Farber Cancer Institute Boston United States.; Choueiri TK; Dana-Farber Cancer Institute Boston, MA United States.; Kwiatkowski DJ; Brigham and Women's Hospital and Harvard Medical School Boston, MA United States.; Freedman M; Dana-Farber Cancer Institute Boston, MA United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

Abou Alaiwi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cardiology, Yale New Haven Hospital, New Haven, CT 06510, USA.; Adib E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA.; Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Institute of Molecular Life Sciences, Center of Excellence of The Hungarian Academy of Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary; HUN-REN-ONKOL-TTK-HCEMM Oncogenomics Research Group, Budapest, Hungary.; Prosz A; Translational Cancer Genomics Group, Danish Cancer Institute, Copenhagen, Denmark.; Cordeiro P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA.; El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medicine, Yale New Haven Hospital, New Haven, CT 06510, USA.; Sztupinszki ZM; Translational Cancer Genomics Group, Danish Cancer Institute, Copenhagen, Denmark; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Nassar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT 06510, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Campbell R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Steinharter JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Larner College of Medicine, University of Vermont, Burlington, VT 05405, USA.; Machiela M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Dutta D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Chanock S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Purdue M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Rockville, MD 20850, USA.; Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Szallasi Z; Translational Cancer Genomics Group, Danish Cancer Institute, Copenhagen, Denmark; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA. Electronic address: sylvan_baca@dfci.harvard.edu.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: toni_choueiri@dfci.harvard.edu.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA. Electronic address: matthew_freedman@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Gulati GS; Vasseur D; Nawfal R; Sotudian S; Semaan K; Eid M; Seo JH; Phillips N; Canniff JJ; Savignano H; Chhetri SB; Jin Z; Ou Y; Bani MA; Lee GM; Trowbridge R; Epstein IB; Rickards G; Cordeiro PRDS; Zhang Z; Chehade REH; James B; Massard C; Italiano A; Hollebecque A; Soria JC; André F; Badoual C; Bellmunt J; Singh H; Aguirre AJ; Wolpin BM; Choueiri TK; Baca SC; Freedman ML

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Garinet S; Department of Medical Oncology, and.; Semaan K; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Li J; Department of Medical Oncology, and.; Zhang Z; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Konda P; Department of Medical Oncology, and.; Sadagopan A; Department of Medical Oncology, and.; Canniff J; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Phillips N; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.; Pandey M; Department of Medical Oncology, and.; Savignano H; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Davidsohn MP; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Lyons K; Department of Medical Oncology, and.; Medda A; Department of Medical Oncology, and.; Khanna P; Department of Medical Oncology, and.; Achom M; Department of Medical Oncology, and.; Fortunato BJ; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Nawfal R; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; El Hajj Chehade R; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; O'Toole J; Department of Medical Oncology, and.; Horst J; Department of Medical Oncology, and.; Freeman D; Department of Medical Oncology, and.; Trowbridge R; Department of Medical Oncology, and.; Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Berchuck JE; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Seo JH; Department of Medical Oncology, and.; Choueiri TK; Department of Medical Oncology, and.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Freedman ML; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Baca SC; Department of Medical Oncology, and.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Viswanathan SR; Department of Medical Oncology, and.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

Gulati GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Da Silva Cordeiro P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Universidade Federal do Ceará (UFC), Fortaleza, CE, Brazil.; Chhetri SB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Fortunato B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Jin Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Chehade REH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Gulati G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Lee GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Hemauer C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Bian W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Sotudian S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Zhang Z; Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Osei-Hwedieh D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA.; Heim TE; Musculoskeletal Oncology Tumor Registry, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; Painter C; Precede Biosciences, Boston, MA.; Nawfal R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Eid M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Vasseur D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Phillips N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Weiss KR; Musculoskeletal Oncology Tumor Registry, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Yang A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee GG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Chhetri S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Chehade REH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Gulati G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Pandey M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Fu D; Department of Biomedical Informatics, Harvard Medical School, Boston MA, USA.; Kim YN; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Sotudian S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Shahbazi SD; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.; Philpot C; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.; Hoggood TA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.; Gulhan DC; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Kellis M; Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA.; Berchuck JE; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Garinet S; Semaan K; Li J; Sadagopan A; Canniff J; Phillips N; Klega K; Panday M; Savignano H; Davidsohn MP; Lyons K; Medda A; Khanna P; Achom M; Konda P; Fortunato BJ; Nawfal R; Chehade REH; Zhang Z; O'Toole J; Horst J; Freeman D; Trowbridge R; Chau CH; Figg WD; Berchuck JE; Crompton BD; Seo JH; Choueiri TK; Freedman ML; Baca SC; Viswanathan SR

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Liu N; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Interdisciplinary Center for Brain Information, Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; Wu J; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Deng E; Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China.; MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.; Zhong J; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Wei B; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Cai T; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Xie Z; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Duan X; Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Fu S; Department of Cellular and Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Osei-Hwedieh DO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Huang K; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Hematology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, JieYang, China.; Internal Medicine Ward I, JieXi People's Hospital, JieYang, China.; Zhuang P; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Sha O; School of Dentistry, Shenzhen University Medical School, Shenzhen, China.; Chen Y; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Interdisciplinary Center for Brain Information, Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; Lv X; Jiangxi Key Laboratory of Oncology, The Third Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Zhu Y; Clinical Research Design Division, Clinical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Zhang L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Lin H; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Li Q; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Lu P; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Miao J; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Interdisciplinary Center for Brain Information, Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; Yamada T; Lecturer, Department of Gastroenterological Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Cai L; Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China.; Du H; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Huang Q; Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China.; Ferrone S; Wang X; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. XWANG30@mgh.harvard.edu.; Xu F; Interdisciplinary Center for Brain Information, Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. fang.xu@siat.ac.cn.; Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology, Shenzhen, China. fang.xu@siat.ac.cn.; Fan X; Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China. fan_xiaoying@gzlab.ac.cn.; GMU-GIBH Joint School of Life Sciences, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China. fan_xiaoying@gzlab.ac.cn.; Fan S; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Guangzhou, China. fansong2@mail.sysu.edu.cn.; Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. fansong2@mail.sysu.edu.cn.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Barbieri, Christopher E; Baca, Sylvan C; Lawrence, Michael S; Demichelis, Francesca; Blattner, Mirjam; Theurillat, Jean-Philippe; White, Thomas A; Stojanov, Petar; Van Allen, Eliezer; Stransky, Nicolas; Nickerson, Elizabeth; Chae, Sung-Suk; Boysen, Gunther; Auclair, Daniel; Onofrio, Robert C; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y; Sheikh, Karen; Vuong, Terry

Nature Genetics. Jun2012, Vol. 44 Issue 6, p685-689. 5p. 1 Diagram, 3 Graphs.

Naqvi SAA; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.; Riaz IB; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA. Electronic address: riaz.irbaz@mayo.edu.; Bibi A; Department of Internal Medicine, University of Oklahoma, Oklahoma City, OK, USA.; Khan MA; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.; Imran M; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.; Khakwani KZR; Department of Internal Medicine, The University of Arizona, Tucson, AZ, USA.; Raina A; Department of Internal Medicine, Canyon Vista Medical Center, Midwestern University, Sierra Vista, AZ, USA.; Anjum MU; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.; Cobran EK; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA.; Warner JL; Center for Clinical Cancer Informatics and Data Science, Legorreta Cancer Center, Brown University, Providence, RI, USA.; Hussain SA; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Singh P; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.; Childs DS; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Orme JJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Mateo J; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Agarwal N; Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Gillessen S; Department of Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland.; Murad MH; Evidence-Based Practice Center, Mayo Clinic, Rochester, MN, USA.; Sartor O; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Bryce AH; Department of Oncology, City of Hope Cancer Center, Goodyear, AZ, USA.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Nawfal, Rashad; Eid, Marc; Semaan, Karl; Paul, Morgan A; Saliby, Renee Maria; Chehade, Razane El Hajj; Machaalani, Marc; Phillips, Noa; Canniff, John; Saad, Eddy; Vasseur, Damien; Zarif, Talal El; Yekeduz, Emre; Sun, Maxine; Baca, Sylvan C; Braun, David; Xie, Wanling; Krajewski, Katherine; Choueiri, Toni

Oncologist

Semaan, Karl; Zarif, Talal El; Eid, Marc; Canniff, John; Phillips, Noa; Fortunato, Bard; Savignano, Hunter; Davidson, Matthew P; Chehade, Razane Hajj; Garinet, Simon; Saad, Eddy; Saliby, Renee Maria; Sun, Maxine; Seo, Ji-Heui; Berchuck, Jacob E; Braun, David; Freedman, Matthew L; Choueiri, Toni K; Baca, Sylvan C

Oncologist

Hwang J; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Likasitwatanakul P; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Deshmukh SK; Department of Medical Affairs, CarisLifeSciences, Irving, Texas.; Wu S; Department of Medical Affairs, CarisLifeSciences, Irving, Texas.; Kwon JJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Toye E; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Moline D; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Evans MG; Department of Medical Affairs, CarisLifeSciences, Irving, Texas.; Elliott A; Department of Medical Affairs, CarisLifeSciences, Irving, Texas.; Passow R; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Luo C; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; John E; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Gandhi N; Department of Medical Affairs, CarisLifeSciences, Irving, Texas.; McKay RR; University of California San Diego, San Diego, California.; Heath EI; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.; Nabhan C; Department of Medical Affairs, CarisLifeSciences, Irving, Texas.; Reizine N; University of Illinois at Chicago, Chicago, Illinois.; Orme JJ; Mayo Clinic, Rochester, Minnesota.; Domingo Domenech JM; Mayo Clinic, Rochester, Minnesota.; Sartor O; Mayo Clinic, Rochester, Minnesota.; Baca SC; Dana Farber Cancer Institute, Boston, Massachusetts.; Dehm SM; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Antonarakis ES; Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, Minnesota.; Department of Medicine, University of Minnesota-Twin Cities, Minneapolis, Minnesota.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Morova T; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.; Ding Y; Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Huang CF; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.; Sar F; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.; Schwarz T; Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Giambartolomei C; Central RNA Lab, Istituto Italiano di Tecnologia, Genova 16163, Italy.; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Baca SC; Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Grishin D; Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Hach F; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.; Department of Urologic Science, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.; Gusev A; Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.; Freedman ML; Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02215, USA.; The Center for Cancer Genome Discovery, Dana Farber Cancer Institute, Boston, MA 02215, USA.; Pasaniuc B; Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Department of Computational Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Lack NA; Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.; Department of Urologic Science, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.; School of Medicine, Koç University, Istanbul 34450, Turkey.; Koç University Research Centre for Translational Medicine (KUTTAM), Koç University, Rumelifeneri Yolu, Istanbul 34450, Turkey.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE